INTERNATIONAL PATENT: MINK THERAPEUTICS, INC. FILES APPLICATION FOR "ALLOGENEIC INVARIANT NATURAL KILLER T CELLS ADJUVANT FOR TREATMENT OF DISEASE AND RELATED METHODS"

GENEVA, May 15 -- MINK THERAPEUTICS, INC. (149 Fifth Avenue, Suite 500New York, NY 10010) filed a patent application (PCT/US2024/054260) for "ALLOGENEIC INVARIANT NATURAL KILLER T CELLS ADJUVANT FOR TREATMENT OF DISEASE AND RELATED METHODS" on Nov 01, 2024. With publication no. WO/2025/097052, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PURBHOO, Marco (149 Fifth Avenue, Suite 500New York, NY 10010)

Abstract: The present disclosure relates to compositions comprising allogeneic invariant natural killer T (iNKT) cells...